Reliq Health Techniques

RHT-X

Analysis and Opinions about RHT-X

Signal
Opinion
Expert
SPECULATIVE BUY
SPECULATIVE BUY
May 2, 2018

They do recommend it in one of their portfolios. The health monitoring business is growing and he would like to see more contracts signed. There are risks as this has a high valuation. He likes the management team. It is a speculative buy.

Show full opinionHide full opinion

They do recommend it in one of their portfolios. The health monitoring business is growing and he would like to see more contracts signed. There are risks as this has a high valuation. He likes the management team. It is a speculative buy.

HOLD
HOLD
April 30, 2018

It is in a good area. Health care in Canada on a monthly basis is number 2 out of the sectors he ranks in Canada. This company is not for the faint of heart. It based for a long time and then exploded higher.

Show full opinionHide full opinion

It is in a good area. Health care in Canada on a monthly basis is number 2 out of the sectors he ranks in Canada. This company is not for the faint of heart. It based for a long time and then exploded higher.

BUY
BUY
April 11, 2018

A past pick and still likes it. The CEO has done an excellent job of delivering on her promises. They monitor healthcare in people's homes. They've announced partnerships with several health authorities, The CEO aims for 30,000 patients
online at USD$50/month. This could lead to impressive cash flow, then later get taken out. Offers an impressive rate of growth.

Show full opinionHide full opinion

A past pick and still likes it. The CEO has done an excellent job of delivering on her promises. They monitor healthcare in people's homes. They've announced partnerships with several health authorities, The CEO aims for 30,000 patients
online at USD$50/month. This could lead to impressive cash flow, then later get taken out. Offers an impressive rate of growth.

TOP PICK
TOP PICK
April 6, 2018

He recommended this back in December and it has done extremely well. The company produces health monitoring devices to remind people to take medication at home. They have 50,000 patients under contract and rolling out at 2000-3000 per month. Yield 0%. (Analysts’ price target is $3.00 )

Show full opinionHide full opinion

He recommended this back in December and it has done extremely well. The company produces health monitoring devices to remind people to take medication at home. They have 50,000 patients under contract and rolling out at 2000-3000 per month. Yield 0%. (Analysts’ price target is $3.00 )

WATCH
WATCH
March 1, 2018

It is almost AI, but it is a healthcare company. There are pretty big cost savings for governments here. There is a real business here and they now need to execute. They just did a bunch of equity raises. This should be the end of the share dilution. They have a nice cash balance behind them. It is high risk, however.

Show full opinionHide full opinion

It is almost AI, but it is a healthcare company. There are pretty big cost savings for governments here. There is a real business here and they now need to execute. They just did a bunch of equity raises. This should be the end of the share dilution. They have a nice cash balance behind them. It is high risk, however.

TOP PICK
TOP PICK
February 28, 2018

This company has software as a service they provide. They link up several medical monitoring devices so it can be monitored by a medical doctor or family. The company has done pilot projects, which have been successful. They are now signing up health authorities. They are signing up about 2000 patients per month. The company wants to be at 30,000 patients by year end, he says. He would add further to his position on a pull-back. Yield 0%. (Analysts’ price target is $3 )

Show full opinionHide full opinion

This company has software as a service they provide. They link up several medical monitoring devices so it can be monitored by a medical doctor or family. The company has done pilot projects, which have been successful. They are now signing up health authorities. They are signing up about 2000 patients per month. The company wants to be at 30,000 patients by year end, he says. He would add further to his position on a pull-back. Yield 0%. (Analysts’ price target is $3 )

HOLD
HOLD
January 24, 2018

This company has just exploded and continues to post up nice numbers. They've been acquiring patients at a very fast rate, and thinks that is going to continue. As they’ve started to move towards being cash flow positive, someone could look at them as an acquisition. He still likes this.

Show full opinionHide full opinion

This company has just exploded and continues to post up nice numbers. They've been acquiring patients at a very fast rate, and thinks that is going to continue. As they’ve started to move towards being cash flow positive, someone could look at them as an acquisition. He still likes this.

TOP PICK
TOP PICK
December 21, 2017

A software company that does virtual wards for patients, where they have sensors around the house reminding patients of things they’re supposed to do. Signed 2 large contracts in the US recently and just signed another one yesterday, and have about 48,000 patients in their pipeline. This saves insurers a lot of money, because instead of having to call somebody up, the sensors do it for them.

Show full opinionHide full opinion

A software company that does virtual wards for patients, where they have sensors around the house reminding patients of things they’re supposed to do. Signed 2 large contracts in the US recently and just signed another one yesterday, and have about 48,000 patients in their pipeline. This saves insurers a lot of money, because instead of having to call somebody up, the sensors do it for them.

TOP PICK
TOP PICK
November 8, 2017

Has a monitoring software that ties into a number of different hardware units. For someone sent home from the hospital, it has the ability to monitor from the home. They have an Alexa type, voice activated monitoring system to remind them to follow procedures. This data is transmitted back to the healthcare team or the family in real time, so they know how your health is doing all the time. It’s supposed to cut down on readmissions. As opposed to selling units to every individual, the company has gone to the health authorities and they basically sell on a long-term contract. Have targeted the US to start with. They are in the process where they are starting to ramp up and hope to be cash flow positive in early 2018. Has a $55 million market cap right now, so there is tons of room to run.

Show full opinionHide full opinion

Has a monitoring software that ties into a number of different hardware units. For someone sent home from the hospital, it has the ability to monitor from the home. They have an Alexa type, voice activated monitoring system to remind them to follow procedures. This data is transmitted back to the healthcare team or the family in real time, so they know how your health is doing all the time. It’s supposed to cut down on readmissions. As opposed to selling units to every individual, the company has gone to the health authorities and they basically sell on a long-term contract. Have targeted the US to start with. They are in the process where they are starting to ramp up and hope to be cash flow positive in early 2018. Has a $55 million market cap right now, so there is tons of room to run.

TOP PICK
TOP PICK
October 12, 2017

They have an automated system to monitor people released from hospital. They provide the software. It allows reporting back to the patient, family, caregivers or health team. They will be profitable late this year or next. They are signing on health authorities into pilot programs and then into long term contracts. It is the health authority’s job to sell the products.

Show full opinionHide full opinion

They have an automated system to monitor people released from hospital. They provide the software. It allows reporting back to the patient, family, caregivers or health team. They will be profitable late this year or next. They are signing on health authorities into pilot programs and then into long term contracts. It is the health authority’s job to sell the products.

WATCH
WATCH
August 12, 2015

Same space as BSM and WebTech Wireless. It is a young start-up with different technology. He owns a little bit, but not one he covers formally. They are finally getting some traction here. He thinks it is one to watch. Interesting idea, but at its early stage. One to watch.

Show full opinionHide full opinion

Same space as BSM and WebTech Wireless. It is a young start-up with different technology. He owns a little bit, but not one he covers formally. They are finally getting some traction here. He thinks it is one to watch. Interesting idea, but at its early stage. One to watch.

Showing 16 to 26 of 26 entries